Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.27
RAD's Cash to Debt is ranked lower than
68% of the 351 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.69 vs. RAD: 0.27 )
Ranked among companies with meaningful Cash to Debt only.
RAD' s 10-Year Cash to Debt Range
Min: 0  Med: 0.03 Max: 0.27
Current: 0.27
0
0.27
Equity to Asset 0.02
RAD's Equity to Asset is ranked lower than
97% of the 335 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.45 vs. RAD: 0.02 )
Ranked among companies with meaningful Equity to Asset only.
RAD' s 10-Year Equity to Asset Range
Min: -0.38  Med: 0.01 Max: 0.41
Current: 0.02
-0.38
0.41
Interest Coverage 2.11
RAD's Interest Coverage is ranked lower than
93% of the 245 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 22.80 vs. RAD: 2.11 )
Ranked among companies with meaningful Interest Coverage only.
RAD' s 10-Year Interest Coverage Range
Min: 0.02  Med: 1.17 Max: 4.75
Current: 2.11
0.02
4.75
F-Score: 6
Z-Score: 2.95
M-Score: -1.29
WACC vs ROIC
16.29%
80.54%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) 3.10
RAD's Operating margin (%) is ranked higher than
53% of the 353 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.95 vs. RAD: 3.10 )
Ranked among companies with meaningful Operating margin (%) only.
RAD' s 10-Year Operating margin (%) Range
Min: -8.84  Med: 0.88 Max: 6.03
Current: 3.1
-8.84
6.03
Net-margin (%) 7.81
RAD's Net-margin (%) is ranked higher than
92% of the 353 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.77 vs. RAD: 7.81 )
Ranked among companies with meaningful Net-margin (%) only.
RAD' s 10-Year Net-margin (%) Range
Min: -11.09  Med: -1.06 Max: 7.95
Current: 7.81
-11.09
7.95
ROA (%) 25.77
RAD's ROA (%) is ranked higher than
99% of the 354 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.43 vs. RAD: 25.77 )
Ranked among companies with meaningful ROA (%) only.
RAD' s 10-Year ROA (%) Range
Min: -29.43  Med: -2.65 Max: 26.68
Current: 25.77
-29.43
26.68
ROC (Joel Greenblatt) (%) 22.17
RAD's ROC (Joel Greenblatt) (%) is ranked higher than
66% of the 353 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.82 vs. RAD: 22.17 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
RAD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -44.02  Med: 4.38 Max: 22.13
Current: 22.17
-44.02
22.13
Revenue Growth (3Y)(%) -4.00
RAD's Revenue Growth (3Y)(%) is ranked lower than
86% of the 290 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.10 vs. RAD: -4.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
RAD' s 10-Year Revenue Growth (3Y)(%) Range
Min: -16  Med: -3.00 Max: 15.1
Current: -4
-16
15.1
EBITDA Growth (3Y)(%) 23.40
RAD's EBITDA Growth (3Y)(%) is ranked higher than
88% of the 261 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.80 vs. RAD: 23.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
RAD' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -84.3  Med: -2.90 Max: 24.5
Current: 23.4
-84.3
24.5
» RAD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

RAD Guru Trades in Q3 2014

Steven Cohen 3,364,900 sh (New)
Ray Dalio 2,124,000 sh (+808.47%)
Joel Greenblatt 12,788,466 sh (+304.20%)
John Burbank 39,265 sh (+259.50%)
Ken Fisher 10,350 sh (unchged)
Andreas Halvorsen Sold Out
Jim Simons Sold Out
George Soros Sold Out
Paul Tudor Jones 54,400 sh (-0.09%)
John Hussman 500,000 sh (-50.00%)
» More
Q4 2014

RAD Guru Trades in Q4 2014

Louis Moore Bacon 1,150,000 sh (New)
NWQ Managers 206,300 sh (New)
Paul Tudor Jones 108,474 sh (+99.40%)
Ray Dalio 2,487,194 sh (+17.10%)
Ken Fisher 10,850 sh (+4.83%)
John Burbank Sold Out
John Hussman Sold Out
Joel Greenblatt 3,434,880 sh (-73.14%)
Steven Cohen 79,200 sh (-97.65%)
» More
Q1 2015

RAD Guru Trades in Q1 2015

Larry Robbins 13,993,398 sh (New)
Jim Simons 5,454,800 sh (New)
John Burbank 4,141,386 sh (New)
Paul Tudor Jones 233,254 sh (+115.03%)
Joel Greenblatt 3,434,883 sh (unchged)
NWQ Managers Sold Out
Steven Cohen Sold Out
Ken Fisher 10,350 sh (-4.61%)
Ray Dalio 1,700,374 sh (-31.63%)
Louis Moore Bacon 100,000 sh (-91.30%)
» More
Q2 2015

RAD Guru Trades in Q2 2015

First Eagle Investment 1,596,105 sh (New)
John Burbank 11,495,343 sh (+177.57%)
Paul Tudor Jones 290,532 sh (+24.56%)
Ken Fisher 11,500 sh (+11.11%)
Louis Moore Bacon 500,000 sh (unchged)
Louis Moore Bacon Sold Out
Joel Greenblatt 3,253,782 sh (-5.27%)
Larry Robbins 12,548,751 sh (-10.32%)
Jim Simons 368,900 sh (-93.24%)
Ray Dalio 70,374 sh (-95.86%)
» More
» Details

Insider Trades

Latest Guru Trades with RAD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Rite Aid Corp

Joel Greenblatt: the Value Investment Magician's Most Recent Buys
Joel Greenblatt (Trades, Portfolio), founder of Gotham Asset Management, is a true value investor. He truly stands behind Warren Buffett (Trades, Portfolio)’s philosophy for buying stocks, which is to buy cheap stocks belonging to a good company. In order to figure out just how good a company is, Greenblatt looks at returns on tangible capital to fulfill his ultimate goal of finding something both cheap and good. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 3.90
RAD's P/E(ttm) is ranked higher than
99% of the 279 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 23.00 vs. RAD: 3.90 )
Ranked among companies with meaningful P/E(ttm) only.
RAD' s 10-Year P/E(ttm) Range
Min: 3.17  Med: 15.92 Max: 6590
Current: 3.9
3.17
6590
Forward P/E 35.34
RAD's Forward P/E is ranked lower than
89% of the 163 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 15.38 vs. RAD: 35.34 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 4.00
RAD's PE(NRI) is ranked higher than
99% of the 279 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 22.90 vs. RAD: 4.00 )
Ranked among companies with meaningful PE(NRI) only.
RAD' s 10-Year PE(NRI) Range
Min: 3.18  Med: 15.45 Max: 219
Current: 4
3.18
219
P/B 53.33
RAD's P/B is ranked lower than
100% of the 333 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.88 vs. RAD: 53.33 )
Ranked among companies with meaningful P/B only.
RAD' s 10-Year P/B Range
Min: 0.29  Med: 1.99 Max: 146.5
Current: 53.33
0.29
146.5
P/S 0.31
RAD's P/S is ranked higher than
64% of the 351 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.50 vs. RAD: 0.31 )
Ranked among companies with meaningful P/S only.
RAD' s 10-Year P/S Range
Min: 0.01  Med: 0.10 Max: 0.35
Current: 0.31
0.01
0.35
PFCF 42.10
RAD's PFCF is ranked lower than
77% of the 197 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 18.51 vs. RAD: 42.10 )
Ranked among companies with meaningful PFCF only.
RAD' s 10-Year PFCF Range
Min: 1.88  Med: 15.29 Max: 80.83
Current: 42.1
1.88
80.83
POCF 10.52
RAD's POCF is ranked higher than
55% of the 264 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 12.22 vs. RAD: 10.52 )
Ranked among companies with meaningful POCF only.
RAD' s 10-Year POCF Range
Min: 0.54  Med: 5.97 Max: 67
Current: 10.52
0.54
67
EV-to-EBIT 16.24
RAD's EV-to-EBIT is ranked lower than
54% of the 300 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 15.56 vs. RAD: 16.24 )
Ranked among companies with meaningful EV-to-EBIT only.
RAD' s 10-Year EV-to-EBIT Range
Min: -477  Med: 18.70 Max: 618
Current: 16.24
-477
618
PEG 0.23
RAD's PEG is ranked higher than
98% of the 141 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.99 vs. RAD: 0.23 )
Ranked among companies with meaningful PEG only.
RAD' s 10-Year PEG Range
Min: 0.18  Med: 0.21 Max: 13.74
Current: 0.23
0.18
13.74
Shiller P/E 61.02
RAD's Shiller P/E is ranked lower than
91% of the 210 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 22.91 vs. RAD: 61.02 )
Ranked among companies with meaningful Shiller P/E only.
RAD' s 10-Year Shiller P/E Range
Min: 25.63  Med: 68.54 Max: 107.4
Current: 61.02
25.63
107.4
Current Ratio 2.42
RAD's Current Ratio is ranked higher than
86% of the 340 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.21 vs. RAD: 2.42 )
Ranked among companies with meaningful Current Ratio only.
RAD' s 10-Year Current Ratio Range
Min: 0.81  Med: 1.83 Max: 3.28
Current: 2.42
0.81
3.28
Quick Ratio 1.25
RAD's Quick Ratio is ranked higher than
79% of the 340 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.75 vs. RAD: 1.25 )
Ranked among companies with meaningful Quick Ratio only.
RAD' s 10-Year Quick Ratio Range
Min: 0.13  Med: 0.46 Max: 1.25
Current: 1.25
0.13
1.25
Days Inventory 55.70
RAD's Days Inventory is ranked lower than
69% of the 346 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 38.45 vs. RAD: 55.70 )
Ranked among companies with meaningful Days Inventory only.
RAD' s 10-Year Days Inventory Range
Min: 56.59  Med: 67.52 Max: 129.21
Current: 55.7
56.59
129.21
Days Sales Outstanding 13.25
RAD's Days Sales Outstanding is ranked lower than
53% of the 287 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 11.10 vs. RAD: 13.25 )
Ranked among companies with meaningful Days Sales Outstanding only.
RAD' s 10-Year Days Sales Outstanding Range
Min: 4.16  Med: 13.43 Max: 19.41
Current: 13.25
4.16
19.41

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 9.41
RAD's Price/Projected FCF is ranked lower than
97% of the 217 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.44 vs. RAD: 9.41 )
Ranked among companies with meaningful Price/Projected FCF only.
RAD' s 10-Year Price/Projected FCF Range
Min: 1.08  Med: 1.98 Max: 10.26
Current: 9.41
1.08
10.26
Price/Median PS Value 3.04
RAD's Price/Median PS Value is ranked lower than
96% of the 336 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.13 vs. RAD: 3.04 )
Ranked among companies with meaningful Price/Median PS Value only.
RAD' s 10-Year Price/Median PS Value Range
Min: 0.09  Med: 1.39 Max: 9.14
Current: 3.04
0.09
9.14
Price/Peter Lynch Fair Value 0.18
RAD's Price/Peter Lynch Fair Value is ranked higher than
98% of the 83 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.62 vs. RAD: 0.18 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
RAD' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.16  Med: 1.46 Max: 29.82
Current: 0.18
0.16
29.82
Earnings Yield (Greenblatt) (%) 6.20
RAD's Earnings Yield (Greenblatt) (%) is ranked higher than
55% of the 352 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.60 vs. RAD: 6.20 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
RAD' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.2  Med: 4.80 Max: 10.3
Current: 6.2
0.2
10.3
Forward Rate of Return (Yacktman) (%) 23.16
RAD's Forward Rate of Return (Yacktman) (%) is ranked higher than
83% of the 224 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 7.39 vs. RAD: 23.16 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
RAD' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -36.6  Med: -1.50 Max: 36.3
Current: 23.16
-36.6
36.3

Analyst Estimate

Feb16 Feb17 Feb18
Revenue(Mil) 30,992 33,789 35,196
EPS($) 0.23 0.40 0.50
EPS without NRI($) 0.23 0.40 0.50

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare:SHDMF, APNHF, GNC, JCOUF, PMC » details
Traded in other countries:RTA.Germany,
Rite Aid Corp a Delaware corporation was incorporated in 1968. It operates retail drugstore chain in the United States. It operates its drugstores in 31 states across the country and in the District of Columbia. As of February 28, 2015, the Company operated 4,570 stores in 31 states across the country and in the District of Columbia. The Company sells prescription drugs and an assortment of other merchandise, which it calls 'front end' products. Front end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other convenience products. The Company attempts to distinguish its stores from other national chain drugstores, in part, through its wellness + loyalty program, private brands and its strategic alliance with GNC, a retailer of vitamin and mineral supplements. The retail drugstore industry is competitive. It competes with retail drugstore chains, independently owned drugstores, supermarkets, mass merchandisers, discount stores, wellness offerings, dollar stores and mail order pharmacies. The Company's business is subject to federal, state, and local government laws, regulations and administrative practices.
» More Articles for RAD

Headlines

Articles On GuruFocus.com
robinhood Jul 11 2015 
robinhood Jul 10 2015 
robinhood Jul 10 2015 
Rite Aid Corporation Posts Impressive Results Jun 23 2015 
Robinhood Jun 18 2015 
Robinhood Jun 18 2015 
Walgreens Boots Alliance, Inc. Dividend Stock Analysis Jun 09 2015 
Larry Robbins' New Buys During Q1 2015 May 29 2015 
Rite Aid Corporation Makes for an Attractive Investment May 29 2015 
CVS Eyeing Omnicare Acquisition To Bolster Market Position May 23 2015 

More From Other Websites
Will Genesco (GCO) Report Dismal Earnings Again in Q2? Aug 31 2015
What's behind Rite Aid call sale Aug 28 2015
Walgreens, CVS Lead Market Relief Rally Aug 25 2015
Four Healthy Drugstore Charts Aug 25 2015
Man Tried to Steal $100 Worth of Toothpaste in the Bronx: NYPD Aug 25 2015
Cramer: The Fed needs to do this now Aug 20 2015
Wal-Mart: Were Pharmacy Benefits as Bad as Shoplifting? Aug 19 2015
Cramer: A Twitter takeover? No way! Aug 18 2015
Consumer watchdog announces Rite Aid, Ikea and Merck product recalls Aug 18 2015
Rite Aid recalls patio sets Aug 18 2015
Rite Aid recalls patio sets Aug 18 2015
Boomers, Pharmacists And Mergers Aug 14 2015
GoPro, Yahoo, Rite Aid Are Buys; Analysts Slam Alibaba Aug 13 2015
Calls Of Note: Wall Street Research Moving The Market On Thursday Aug 13 2015
Why CVS Health’s Stock Fell after Its 2Q15 Earnings Release Aug 13 2015
Jim Cramer: Rite Aid and GW Pharmaceuticals Are Ripe for a Rally Aug 13 2015
The Resurrection Of Rite Aid Aug 13 2015
Cramer's Mad Dash: Rite Aid & GW Pharma Aug 13 2015
Coverage initiated on Rite Aid by BofA/Merrill Aug 13 2015
Rite Aid (RAD) Finally Comes Around to Using Apple Pay Aug 12 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK